17 October 2022
Joint statement on the KVV/OAMal and KLV/OPAS revision
29 June 2022
RDAF newsletter – June 2022
06 October 2021
RDAF statement on the Federal Council report on rare diseases
19 March 2021
RDAF statement for the public consultation on the adjustment of various ordinances which are needed to implement the revised Swiss Invalidity Insurance
03 October 2022
The Rare Disease Action Forum (RDAF) advocates for a fair and rapid access to high-quality treatment for patients with rare diseases in Switzerland.
26 April 2022
Multi-stakeholder workshop report – Market access for orphan drugs in Switzerland
14 July 2021
Report of the RDAF Multi-Stakeholder Workshop on Registries for Rare Diseases
10 December 2020
RDAF statement for the public consultation on he revision of the Federal Health Insurance Act concerning package 2 of the cost containment measures
16 September 2022
RDAF position statement on KVV/KLV revision
22 December 2021
RDAF activities in 2021 and outlook for 2022
19 April 2021
Webinar report – Access to diagnosis and treatment of rare diseases in Switzerland Current status, challenges and initiatives (25 March 2021)
25 June 2020
Multi-stakeholder workshop report – Registries for rare diseases in Switzerland (8 April 2020)